Robert Padgett
Family Medicine · Aledo, ILNPI 1306832910
Payments from drug & device makers
Across 339 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$857
- AstraZeneca$492
- Pfizer$449
- Amgen$360
- Boehringer Ingelheim$336
- Novartis$317
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,171100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $857 |
| AstraZeneca | 27 | $492 |
| Pfizer | 38 | $449 |
| Amgen | 23 | $360 |
| Boehringer Ingelheim | 20 | $336 |
| Novartis | 19 | $317 |
| Exact Sciences | 19 | $296 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $251 |
| Otsuka America Pharmaceutical, Inc. | 16 | $228 |
| Teva Pharmaceuticals USA, Inc. | 12 | $203 |
| Supernus Pharmaceuticals, Inc. | 7 | $139 |
| Gilead | 8 | $130 |
| Novo Nordisk | 8 | $124 |
| Lilly USA, LLC | 8 | $123 |
| E.r. Squibb & Sons, L.L.C. | 8 | $123 |
| Alkermes, Inc. | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Johnson & Johnson | 4 | $50 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Kyowa Kirin, Inc. | 2 | $47 |
| Esperion Therapeutics, Inc. | 1 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $40 |
| Astellas Pharma US Inc | 3 | $40 |
| Stryker | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Bayer | 2 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 2 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $12 |
How this compares
$5,185 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 91 | $103,240 |
| EliquisApixaban | 74 | $66,107 |
| JardianceEmpagliflozin | 54 | $63,510 |
| JanuviaSitagliptin Phosphate | 15 | $18,601 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 17 | $13,758 |
| MounjaroTirzepatide | 13 | $13,617 |
| MyrbetriqMirabegron | 12 | $12,361 |
| Xtampza ErOxycodone Myristate | 13 | $11,833 |
| TrulicityDulaglutide | 11 | $9,606 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $9,328 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 28 | $8,092 |
| TradjentaLinagliptin | 11 | $6,919 |
| Fentanyl | 79 | $6,529 |
| Praluent PenAlirocumab | 12 | $6,339 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 31 | $6,085 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $124 | $103,24091 claims |
| Boehringer IngelheimJardiance, Tradjenta | $336 | $70,42965 claims |
| PfizerEliquis | $449 | $66,10774 claims |
| Lilly USA, LLCMounjaro, Trulicity | $123 | $23,22324 claims |
| AstraZenecaBevespi Aerosphere | $492 | $13,75817 claims |
| Astellas Pharma US IncMyrbetriq | $40 | $12,36112 claims |
| Sanofi-aventis U.S. LLCLantus | $40 | $1,47516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Aledo
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.